Single-Tier Lyme Disease Test Improves Detection in Early Infection
A peer-reviewed study reports ACES Diagnostics’ LymeSeek immunoassay achieved 90% sensitivity for early Lyme disease detection within two weeks of symptom onset.
Latest Articles
Editor's Top Picks
CMS Releases Preliminary 2027 CLFS Rates as CAP Calls for Payment Reform
CMS has released preliminary 2027 CLFS rates, with data showing weighted median payment cuts for over 1,100 test codes; annual reductions are capped at 15% from 2027 to 2029 under current policy.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
MIT Engineers Develop Handheld Device to Collect Viable Cells for Early Cancer Detection
Using microfluidic shear stress, the system detaches living cells from excised tissue to support pathology workflows and downstream diagnostic testing.
Equipment & Supply Spotlight
The Untapped Value of Longitudinal Laboratory Data
Laboratories hold years of patient test results, but much of that data remains fragmented and underused despite its potential value for patient care and reimbursement.
News, Know-How & Standards
Disease Detection & Understanding
Lund University Secures $19.4M NIH Grant to Validate Staging Blood Test for Alzheimer’s
Lund University has received a $19.4 million NIH grant to clinically validate a new blood biomarker test for Alzheimer’s, assessing MTBR-tau243 and p-tau217 for improved disease staging and diagnostic accuracy.
